today announced that the Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel. This treatment is indicated for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback